Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias

T315I(+) Philadelphia chromosome–positive leukemias are inherently resistant to all licensed tyrosine kinase inhibitors, and therapeutic options remain limited. We report the outcome of allogeneic stem cell transplantation in 64 patients with documented BCR-ABL(T315I) mutations. Median follow-up was...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood
Hlavní autoři: Nicolini, Franck Emmanuel, Basak, Grzegorz W., Soverini, Simona, Martinelli, Giovanni, Mauro, Michael J., Müller, Martin C., Hochhaus, Andreas, Chuah, Charles, Dufva, Inge H., Rege-Cambrin, Giovanna, Saglio, Giuseppe, Michallet, Mauricette, Labussière, Hélène, Morisset, Stéphane, Hayette, Sandrine, Etienne, Gabriel, Olavarria, Eduardo, Zhou, Wei, Peter, Senaka, Apperley, Jane F., Cortes, Jorge
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2011
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4916555/
https://ncbi.nlm.nih.gov/pubmed/21926354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-07-367326
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky